Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Cappuzzo

Showing results (271-280 of 275) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 275 results.
Therapeutic Advances in Medical Oncology|February 17, 2022
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world settingLaura Pizzuti, Eriseld Krasniqi, Isabella Sperduti, et al.
Frontiers in Oncology|June 1, 2023
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from <i>CaRe</i>, a multicentric, observational studyFrancesca Sofia Di Lisa, Eriseld Krasniqi, Laura Pizzuti, et al.
Cancer Discovery|April 17, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLCMarcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti, et al.
Translational Lung Cancer Research|November 4, 2021
Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancerBin Qiu, Kaican Cai, Chun Chen, et al.
Nature Genetics|September 4, 2012
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerMartin Peifer, Lynnette Fernández-Cuesta, Martin L Sos, et al.
Pageof 28

Showing results (271-280 of 275) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 275 results.
Therapeutic Advances in Medical Oncology|February 17, 2022
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world settingLaura Pizzuti, Eriseld Krasniqi, Isabella Sperduti, et al.
Frontiers in Oncology|June 1, 2023
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from <i>CaRe</i>, a multicentric, observational studyFrancesca Sofia Di Lisa, Eriseld Krasniqi, Laura Pizzuti, et al.
Cancer Discovery|April 17, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLCMarcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti, et al.
Translational Lung Cancer Research|November 4, 2021
Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancerBin Qiu, Kaican Cai, Chun Chen, et al.
Nature Genetics|September 4, 2012
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerMartin Peifer, Lynnette Fernández-Cuesta, Martin L Sos, et al.
Pageof 28